Exhibitors

Abbott

Abbott’s CardioMEMS™ HF System provides the actionable data you need to empower intelligent remote monitoring. The system allows you to better understand your patients' heart failure progression and treatment needs.

Alta Thera Pharmaceuticals

AltaThera is a precision medicine company using innovative science to improve patient care by narrowing the gap between scientific innovation and decision-making. For more information, please visit altathera.com.

Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

CicaLux/heart&core Sports & Medical LLC

CicaLux Energized Scar-Care is a combination therapy device designed to help prevent or improve hyper-pigmented, hypertrophic (raised) and/or keloid scars resulting from incisional surgeries.

Janssen Pharmaceuticals

The Janssen Pharmaceutical Companies of Johnson & Johnson never stop working to create a future where cardiovascular disease is a thing of the past.

Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals is a global biopharmaceutical company that finds and delivers novel treatments for patients with significant unmet need. In March 2021, Kiniksa received FDA approval for ARCALYST® (rilonacept). Visit www.arcalystbooth.com/pcna23 to learn more.

Lexington Medical Center

Consistently named best hospital, Lexington Medical Center dedicates itself to providing quality health services that meet the needs of its communities.

LSI (Life Systems International)

LSI leads the way in providing time-saving cardiac rehab monitoring and management solutions. For more than 35 years, LSI has delivered trusted technology and customized solutions.

MedTech International Group

Med-Tech International is a mission-driven company. For us, that means a strong collaboration with our clinical partners to continuously deliver innovative and alternative therapies to fulfill clinical needs and improve patient outcomes.

Merck

Cardio-Metabolic Disorders
We are determined to find solutions for the most serious chronic health challenges, such as cardiovascular disease and diabetes.

Milestone Pharmaceuticals

We are a patient-centric, clinical-stage biopharmaceutical company dedicated to bringing an investigational medication to patients living with paroxysmal supraventricular tachycardia (PSVT) and atrial fibrillation (AFib), as well as other episodic cardiovascular conditions.

Novartis Pharmaceuticals Corp

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. We rank among the world’s top companies investing in R&D, and our products reach nearly 800 million people globally.

Novo Nordisk

For 95 years, Novo Nordisk, a global leader in healthcare, has been committed to discovering and developing innovative medicines to help people with chronic diseases lead longer, healthier lives.

Pfizer

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

Regeneron Pharmaceuticals, Inc.

Regeneron is a biotechnology company that develops medicines for serious diseases. Founded by physician-scientists, their ability to translate science into medicine has led to numerous FDA-approved treatments and investigational candidates.